The potential health and ecological effets of endocrine disrupting chemicals has become a high visibility environmental issue. The 1990s have witnessed a growing concern, both on the part of the scientific community and the public, that environmenta chemicals may be causing widespread effects in humans and in a variety of fish and wildlife species. This growing concern led the Committee on the Environment and Natural Resources (CENR) of the National Science and Technology Council to identify the endocrine disruptor issue as a major research initiative in early 1995 and subsequently establish an ad hoc Working Group on Endocrine Disruptors. The objectives ofthe workdng group are to 1) develop a planning amework fior federal researcl reated to human and ecological health effects of endocrine disrupting chemicals; 2) conduct an inventwry of ongoing federal research programs; and 3) identify research gaps and develop a coordinated interagency plan to address priority research needs. This communication su aize the activities of the federal government in defining a common framework for planning an endocrine disruptor research program and in assessing the status of the current effort. After devdoping the research framework and compiling an inventory of active research projects supported by the federal government in fiscal year 1996, the CENR working group evaluated the current federal effort by comparing the ongoing activities with the research needs identified in the framework
The analysis showed that the federal government supports considerable research on human health effects, ecological effet, and exposure assessment, with a predominance of activity occurring under human health efects. The analysis also indicates that studies on reproductive development and carcinogenesis are more prevalent than studies on neurotoxicity and immunotoxicity, that mammals (mostly laboratory animals) are the main species under study, and that chlorinated dibenzodioxins and polychlorinated biphenyls are the most commonly studied chemical dases.
Comparison of the inventory with the research needs should allow identification of underrepresented research areas in need of attention. Key workls carcinogenicity, developmental toxicity, endocrine disruptor, immunotoxicity, neurotoxicity, risk assessment Environ Health Perpct 106: 105-113 (1998) . [Online 28 January 1998] hstp:llehpnetl.nichs.nib.gov/docs/)998/106p105-113reiterlabstract tml Over the last few years, there has been a growing concern that both synthetic and naturally derived chemicals may be causing a variety of unwanted health effects in both humans and wildlife populations due to their ability to impact the function, especially during developmental stages, of the endocrine system. In response to this concern, a federal interagency effort to coordinate research on endocrine disrupting chemicals was initiated through the President's National Science and Technology Council (NSTC). The NSTC is chaired by the president and its membership includes the vice president, the president's cabinet, and high-level advisors to the president, including John H. Gibbons, science advisor to the president. The NSTC is specifically charged with ensuring that science and technology are considered in the formulation of federal policies and that the federal organizations have coordinated science and technology budgets and programs. The NSTC has several committees. One is the Committee on Environment and Natural Resources (CENR), which is responsible for coordinating environment and natural resources research and development across the federal agencies. The CENR has established five top priorities for the administration's environment and natural resources research and development investment. * Global climate change * National environmental monitoring and research * Natural disaster reduction * North American research strategy for troposphere ozone * Endocrine disruptors.
Work on the endocrine disruptors initiative began in the fall of 1995 with the establishment of a Working Group on Endocrine Disruptors, chaired by the EPA and cochaired by the U.S. Geological Survey and the Department of Health and Human Services. Participating departments and agencies are listed in Table 1 . The objectives of this interagency working group are very specific: 1) develop a planning framework for federal research on human health and ecological effects of endocrine disrupting chemicals; 2) conduct an inventory to identify the nation's resources, current research projects, and the scientists conducting them; and 3) identify research gaps and facilitate a coordinated interagency research plan to address them.
As of November 1996, the first two goals have been accomplished, and a meeting was sponsored at the Smithsonian Institution to communicate efforts of the U.S. government to coordinate research activities on the general topic of endocrine disruptors. The primary purposes of the meeting were to share the framework for research needs agreed upon across the key federal organizations and to provide a preliminary analysis of the existent The CENR anticipates continued interaction with these forums and activities as the field matures over the next few years.
The CENR Framework
To provide data relevant to the formulation of sound environmental policy for endocrine disruptors, the working group framed the research needs in the context of general risk-based principles (1). Three broad types of research activities were identified to support the risk assessment process: methods, models, and measurements (Fig. 1) . These three categories of research needs were further subdivided into nine broad subcategories: hazard identification, biomarkers, risk models, basic research, mixtures, exposure determinations/follow-up, multidisciplinary studies, sentinel species, and database development. Methods. Methods need to be developed and validated for identifying/characterizing hazards. These hazard identification methods should be rapid, reliable, and inexpensive; should screen chemicals for endocrine disrupting potential; and should provide presumptive evidence of causality between exposure and effects. Biomarkers represent a special need in the methods development area. These biomarkers will be critical for determining 1) the occurrence of exposure to a particular chemical, 2) a response specific to exposure to a chemical or chemical class, and 3) the existence of susceptible species or subpopulations based on some genetic trait.
Models. For dose-response and exposure assessments, research involves development and validation of predictive models of dose, effect, and transport/fate that permit integration and extrapolation of data. Basic research on mechanisms of action is essential to better understand the interplay between chemicals implicated as potential endocrine disrupting chemicals in whole organisms and the endocrine system. Baseline data on endocrine regulation in immature and adult organisms are required to reduce uncertainties surrounding age-dependent responses. There is also a need to understand the key events involved in hormone action and the linkage between those events and a toxic response. Risk models for endocrine-mediated effects need to be developed and refined. Research aimed at improving risk assessment models should focus on 1) improving estimates of target organ dosimetry subsequent to environmental concentrations of endocrine disrupting chemicals, 2) estimating exposure, and 3) more accurately predicting the environmental and human health consequences following exposure to endocrine disrupting chemicals. Little is known about the hazards of chemical mixtures, and a sound scientific Figure 1 . Overview of the structure for the framework to address research needs for endocrine disrupting chemicals. The framework is based upon the National Academy of Science paradigm for risk assessment and identifies major research categories of methods to support hazard identification activities, models to predict exposure and dose-response relationships, and measurement of exposure and biological responses in actual environmental settings. The framework is further developed into nine subcategories of research that support the three primary research categories. Compilation of the research inventory followed the same framework. 
Human Health Research
Of the 396 research projects included in the present CENR endocrine disruptor inventory, 273 (69%) listed human health effects as their primary focus. Approximately 21% of these fell under the Methods category, 57% under Models, and 21% under Measurements. The health effects projects were examined according to the toxicological endpoints of carcinogenicity, immunotoxicity, neurotoxicity, and reproductive and developmental toxicity. As shown in Table 2 , the largest number of projects in the inventory was in reproductive and developmental toxicity, followed by carcinogenicity, neurotoxicity, and immunotoxicity.
The category "none specified" includes human health effects projects that did not specify one of the other toxicological endpoints. The breakdown of the health effects projects by endpoint yields a total that is larger than the total number of health effects projects because several projects address more than one experimental endpoint (e.g., both carcinogenicity and reproductive toxicity). A large number of projects listed for a given endpoint does not necessarily mean that the topic is being investigated sufficiently to support risk assessments for endocrine disruptors. To explore the utility of the present inventory of research projects for evaluating human risk, the health effects projects were examined by toxicological endpoint according to their distribution within the planning framework subcategories ( General conclusions ofhuman health research. Two recurring themes are evident from this analysis ofthe federal endocrine disruptor research inventory of human health effects projects. First, basic research is the subcategory that contains the largest number of projects for each of the toxicological endpoints examined. This is not too surprising, because a large number of the projects in the inventory are sponsored by the National Institutes of Health (NIH) and the NSF and because interest in endocrine disruption as a toxicological mechanism has expanded enormously in recent years. Many basic research projects are relevant to the role of the endocrine system during development (e.g., of the nervous system or reproductive system) or examine effects of altered endocrine functioning; however, few address effects of exposure to endocrine disrupting chemicals and human risk. These projects are included in the inventory because it is expected that they will contribute to our understanding of adverse effects mediated via the endocrine system and thereby be useful for assessing whether and how specific toxicological effects are produced by an endocrine disrupting mechanism. Although the basic research projects in the inventory are valuable for advancing the science on endocrine disruption, more effort will be needed to link these mechanistic data to assessments of human health risk. The second consistent finding is that studies on health effects of mixtures are not being addressed to any considerable extent. We expect the distribution of projects to change as the inventory expands and high priority research needs are identified.
Ecological Research
Nine federal organizations submitted projects with ecological effects as the primary focus area. Five organizations submitted a total of nine projects, which leaves four organizations-the NSF, the Department of Interior, the EPA, and the National Oceanic and Atmospheric Administration -responsible for the majority of the ecological research.
The analysis is organized by the nine subcategories within the three major categories of Methods, Models, and Measurements. In a few cases, a category or subcategory other than that listed in the project was assigned to enhance consistency in the designation of categories across projects.
In Attributes associated with sentinel species indude sensitivity to pollutants, widespread distribution, suitability for field and laboratory research, and a well-understood biology. Projects listed in the inventory develop information on four species that appear to meet enough of these criteria to be considered as sentinels: American kestrel (Falco sparverius), mink (Mustela vison), river otter (Lutra canadensis), and English sole (Pleuronectes vetulus). Another topic area identified under the subcategory of sentinel species is that of historically neglected species. Research is being directed on two animal groups that have been overlooked in ecotoxicological efforts: amphibians and dolphins. There are no efforts described in the inventory that focus on database development, the last subcategory.
While a broad range of chemicals are listed as agents under study in the inventory ( Two areas of focus that were evident in the inventory stimulate further discussion. The first is the overwhelming number of ecological effects projects targeting the reproduction endpoint. The benefit of this emphasis is that reproduction has often been shown to be the most sensitive significant endpoint in wildlife that can result from xenobiotic exposure, thus offering the best chance of documenting injury. The question to be raised is whether this focus may compromise the ability to expand the knowledge base for the other endpoints, particularly those critical to ecological health such as immunotoxicity and growth/metamorphosis.
The second focus area that emerged is the significance of the abnormal vitellogenin response in males. The notoriety and utility of this response has generated a number of projects dedicated to the development of techniques that could eventually be used as screening bioassays for endocrine activity or even biomarkers of exposure in wild populations. The concern about this emphasis is that the relevance ofvitellogenin in the blood of males to either individual health or to the viability ofthe population is not known.
Exposure Studies
The third focal area of the research inventory includes exposure studies that address the extent of exposure or the potential for exposure to endocrine disruptors. Exposure assessment is critical to assessing the potential for human and wildlife exposure to endocrine disruptors, establishing priorities for hazard identification, monitoring trends in contaminated media and body burdens, determining baseline levels to assess the impact of interventions, validating exposure and health effects associations, and reducing uncertainties in risk assessment. Exposure assessment is the least represented area of the research inventory with only 13% (53/396) of projects identifying exposure assessment as their primary focus (however, an additional 59 projects identified exposure as a secondary focal area of activity, which undoubtedly reflects the need to have exposure data to support any projected association between exposure and effects). For the purposes of this research inventory, exposure assessment has been defined to indude the measurement or estimation of the magnitude, frequency, duration, and route of exposure to substances in the environment or in biological tissues. Also included under exposure assessment are studies that address demographics by linking the size and nature of the exposed populations to the parameters of chemical exposure. Not included in this focal area are studies that address the projected association between exposure and Volume 106, Number 3, March 1998 * Environmental Health Perspectives effect or research addressing the development of biological markers for susceptibility and effect.
As with the other areas of the inventory, three categories were reviewed. These induded Methods, Models, and Measurements (Table 7) . Methods and models represent the tools used in conducting exposure assessments, and they are employed to identify levels of endocrine disruptors in both media and tissues. Research in these categories indudes such projects as the development of gene probes for the diagnosis of exposure to steroids and recombinant detection methods for dioxinlike chemicals that can be used in dose reconstruction, and models used to estimate levels of endocrine disruptors in contaminated media and tissues. Examples include models to estimate organochlorine exposure and associated breast cancer risk and the development of molecular biomarkers ofpesticide resistance in mosquito fish. In contrast to models and methods, measurement research represents the application of these tools to define actual levels of endocrine disruptors in environmental media and tissues. Examples include measurements of serum pesticides and PCBs in relation to breast cancer, as well as the measurement of PCBs and dieldrin burden among native Americans. As such, these measurements represent the systematic collection of information for subsequent analysis and potential linkage to health effects. Table 8 provides a breakout of exposure assessment studies by subcategories. In this breakout it is clear that sentinel species, as well as mixtures research, may be underrepresented, at least from a numerical perspective. The same possibly would be true of database development. However, not all studies in the inventory reflect the same scope of effort. Thus, some projects listed under database development, such as the NHANES (National Health and Nutrition Examination Survey) study and other exposure inventories are clearly large in scope.
This suggests that a greater emphasis is placed in the area of database development than would otherwise be indicated by the fact that only six studies identify database development as their primary focus.
In terms of the range of chemicals being assessed, PCBs, dioxins, and DDT are highly represented, with other compounds possibly underrepresented (Table 9 ). Small numbers of projects identified other potential endocrine disrupting chemicals such as alkylphenols (nine projects), phthalate esters (five projects), and nonpersistent pesticides (nine studies).
A further breakout of these studies by agent and endpoint is shown in Table 10 for those studies that provided relevant keywords in the appropriate data fields. (6) 31 (2) 52 (8) Total 53 (8) 59 (9) 112 (17) "Numbers presented as number of projects identified with a primary research category (secondary research category). As noted above, a major focus in the inventory appears to be on human studies, which is reported to be the focus of 64 of the total of 112 exposure assessment studies; however, closer examination of the individual projects with exposure assessment as the primary or secondary focus indicates that only 24 actually involve examination of relationships between exposure and outcomes in populations. The majority of these studies focused on issues related to breast cancer. Many of the projects identified as human oriented used human cell lines in vitro or examined various food sources for levels of endocrine disrupting chemicals. Only limited studies for invertebrates (n = 1), amphibians (n = 3), birds (n = 1), and reptiles (n = 1) were reported. The immune system (n = 9) appears to be the most underrepresented issue from a biological endpoint perspective. None of the four primary biological endpoints (reproductive, carcinogenic, neurologic, or immunologic) were indicated for a significant number of projects that identified exposure assessment as a primary or secondary focal area. With reference to the chemicals under study, there appears to be a reasonable distribution of chemicals being studied, although the emphasis has been on oral contraceptives and persistent organochlorines, with much less work in other areas (e.g., phthalates, nonpersistent pesticides, and phytoestrogens). With respect to demographics, there is a general lack of exposure assessment information on vulnerable groups, both in terms of critical life stage and life style.
Summary and Conclusions
This is the first comprehensive effort to evaluate the involvement of the federal government in endocrine disruptor research. The analysis of the inventory provides a powerful tool to evaluate the strengths and weaknesses of current research efforts relative to the key uncertainties in the state of the science. The federal government is supporting a considerable amount of research on the topic, and several organizations have been actively working in the area over the past few years. By actively analyzing the current level of effort, the working group expects to assist the overall risk assessment process for endocrine disruptors by 1) ensuring that the federal investment is appropriately focused on the correct questions and uncertainties; 2) facilitating the coordination among the organizations to maximize the complementary nature of the research and to minimize duplications; and 3) providing the forum and means by which a coordinated federal program can have a reasonable probability of success.
The inventory analysis indicates that the overall effort is largest in human health research and in model development. Nearly 80% of the projects are contained within three subcategories: basic research, hazard identification, and exposure/risk models. Major research gaps identified in the analysis of the human health, ecological, and exposure research areas are presented in Table  12 . Research targeted at developing predictive fate and transport models for specific endocrine disrupting chemicals and predictive dose-response models for potential endocrine disrupting chemical-related diseases are particularly needed in order to improve the foundation of future risk assessment and risk management activities. Within biological endpoints, there is a reasonable emphasis on effects on reproduction and development, but effects on other systems, particularly for wildlife, are lacking. As laboratory and field studies increase in number, it is important that they consider multidisciplinary examinations so that the full ranges of biological responses can be identified and characterized. Additional biomarkers of response and the use of sentinel species for environmental studies should assist in the expanded characterization of hazard and risk. For wildlife studies, inclusion of growth and metamorphosis endpoints should be encouraged for relevant species; information on the normal ontogenetic endocrine patterns and their role in regulation of differentiation is needed; and the range of species covered should be expanded. As to chemicals under study, there is a dear dominance in studies on Ah and estrogen receptor ligands and related structural chemicals; much less attention is being placed on contemporary-use industrial chemicals and pesticides that may interact with the endocrine system via mechanisms independent of direct steroid-receptor binding (e.g., increased bioavailability due to displacement of hormones from serum-transport proteins or increased metabolic turnover through induction of liverconjugating enzymes). Finally, work is needed to better understand the biological responses of exposure to multiple endocrine disrupting chemicals, both from the view of specific chemical mixtures and, more importantly, from the standpoint of developing generally applicable predictive models ofjoint action.
The member organizations of the CENR working group are committed to developing an integrated strategic plan to address the major gaps and uncertainties for endocrine disruptors. The establishment of the CENR framework, the development of the inventory, and the analysis of the match of the inventory to the framework provide the foundation for this process. Individual organizations must now take this information and develop research strategies based upon their respective missions. These must be widely circulated so that the various components of the federal effort remain informed of activities ofsister organizations, thus allowing the total effort to become better coordinated and complementary. An Volume 106, Number 3, March 1998 * Environmental Health Perspectives More focused research to further establish priorities across organizations and thereby promote integration and collaboration among those in the federal sector and elsewhere pursuing research with respect to exposure to endocrine disruptors
Increased support for studies of fate and transport, particularly for new chemicals that may cause endocrine disruption iterative process is needed by which federal organizations supporting research on endocrine disruptors can evaluate the roles of their research programs in a larger context of national research needs on endocrine disruptors and contributions of sister organizations to these needs. The framework document and federal research inventory described in this paper provide the means to do this. Moreover, the CENR provides a coordinating mechanism for participating federal units to continue to evaluate research needs and exchange information.
A truly coordinated research strategy on endocrine disruptors should also include international information exchange and exchange of information with the private sector. Environmental Health Perspectives * Volume 106, Number 3, March 1998 1 1 3
